PERSEUS · EFC16035
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase 3, randomized, double-blind study evaluating the efficacy and safety of SAR442168 versus placebo in patients with primary progressive multiple sclerosis. EudraCT: 2020-000645-14.
Sponsor: SANOFI
Phase: III
Area: Neuroimmunology